Lysostaphin in treatment of neonatal Staphylococcus aureus infection. 2007

Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
Baylor College of Medicine and Perinatal Center, Texas Children's Hospital, 6621 Fannin St., FC830.17, Houston, TX 77030-2799, USA.

This study describes lysostaphin's effect against methicillin-sensitive Staphylococcus aureus in suckling rats. Standard techniques determined minimal inhibitory and bactericidal concentrations, pharmacokinetics, and efficacy. The numbers of surviving rats after vancomycin, oxacillin, and lysostaphin treatment were comparable and were different from that of controls (P < 0.00001). Lysostaphin appears effective in the treatment of neonatal S. aureus infection.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008248 Lysostaphin A 25-kDa peptidase produced by Staphylococcus simulans which cleaves a glycine-glcyine bond unique to an inter-peptide cross-bridge of the STAPHYLOCOCCUS AUREUS cell wall.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000833 Animals, Suckling Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed. Animal, Suckling,Suckling Animal,Suckling Animals
D000891 Anti-Infective Agents, Local Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. Anti-Infective Agents, Topical,Antiseptic,Antiseptics,Microbicides, Local,Microbicides, Topical,Antiinfective Agents, Local,Antiinfective Agents, Topical,Local Anti-Infective Agents,Local Antiinfective Agents,Topical Anti-Infective Agents,Topical Antiinfective Agents,Agents, Local Anti-Infective,Agents, Local Antiinfective,Agents, Topical Anti-Infective,Agents, Topical Antiinfective,Anti Infective Agents, Local,Anti Infective Agents, Topical,Local Anti Infective Agents,Local Microbicides,Topical Anti Infective Agents,Topical Microbicides
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.

Related Publications

Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
April 2009, Pediatric research,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
November 2007, The Journal of antimicrobial chemotherapy,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
May 2000, Investigative ophthalmology & visual science,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
September 2021, Journal of applied microbiology,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
May 1992, Zhonghua wai ke za zhi [Chinese journal of surgery],
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
September 2006, Journal of bacteriology,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
July 1970, Journal of bacteriology,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
June 1998, Antimicrobial agents and chemotherapy,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
May 2024, International journal of biological macromolecules,
Okunola Oluola, and Lingkun Kong, and Mindy Fein, and Leonard E Weisman
September 1964, Journal of bacteriology,
Copied contents to your clipboard!